USP18 is downregulated in an osteoporosis model and alleviates osteoblast inflammation and apoptosis by deubiquitinating TAK1 to inhibit the MAPK pathway.
- DOI
- 10.1007/s10616-026-01068-7
- Published
- 2026 Oct
- Container
- Cytotechnology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10616-026-01068-7,
title = {USP18 is downregulated in an osteoporosis model and alleviates osteoblast inflammation and apoptosis by deubiquitinating TAK1 to inhibit the MAPK pathway.},
author = {Chen G and Liang J and Cui Y and Wei J and Xu Y},
year = {2026},
journal = {Cytotechnology},
doi = {10.1007/s10616-026-01068-7},
url = {https://doi.org/10.1007/s10616-026-01068-7}
}RIS
TY - JOUR TI - USP18 is downregulated in an osteoporosis model and alleviates osteoblast inflammation and apoptosis by deubiquitinating TAK1 to inhibit the MAPK pathway. AU - Chen G AU - Liang J AU - Cui Y AU - Wei J AU - Xu Y PY - 2026 JO - Cytotechnology DO - 10.1007/s10616-026-01068-7 UR - https://doi.org/10.1007/s10616-026-01068-7 ER -
APA
G, C., J, L., Y, C., J, W., & Y, X. (2026). USP18 is downregulated in an osteoporosis model and alleviates osteoblast inflammation and apoptosis by deubiquitinating TAK1 to inhibit the MAPK pathway.. Cytotechnology. https://doi.org/10.1007/s10616-026-01068-7
Source records
- pubmed · retrieved 2026-09-27T15:52:19.394Z